In this post, apart from Nature Reviews Drug Discovery Impact Factor, I have tried to compile all the necessary information a research scholar would seek before publishing an article in the journal.
About Nature Reviews Drug Discovery Journal
Nature Reviews Drug Discovery is a peer-reviewed journal from Nature Publishing Group. It is a monthly journal aimed at everyone working in the drug discovery and development arena.
In addition to the highest-quality reviews and perspectives covering a broad scope, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in areas such as new drug approvals, patent law and emerging industry trends and strategies.
Impact Factor
SJR Rank
H-index
Impact Factor of Nature Reviews Drug Discovery Journal
Impact Factor (IF) or often called journal impact factor (JIF) is an index provided by an analytics company named Clarivate. The impact factor is calculated by dividing the number of times the articles are cited in the last two years by the total number of publications in those two years.
- Total Citations in 2020 and 2021 = 500
- Total Number of Publications in 2020 and 2021 = 100
- Impact Factor of the Journal in 2022 = 500/100 = 5
Latest Nature Reviews Drug Discovery Impact Factor (2017-2023)
- Nature Reviews Drug Discovery Impact Factor 2017 – 50.167
- Nature Reviews Drug Discovery Impact Factor 2018 – 57.618
- Nature Reviews Drug Discovery Impact Factor 2019 – 64.797
- Nature Reviews Drug Discovery Impact Factor 2020 – 84.694
- Nature Reviews Drug Discovery Impact Factor 2021 – 112.288
- Nature Reviews Drug Discovery Impact Factor 2022 – 120.1 (updated in June 2023)
Nature Reviews Drug Discovery Impact Factor 2022
Nature Reviews Drug Discovery H-index
The h index is a metric for evaluating the cumulative impact of an author’s scholarly output and performance; measures quantity with quality by comparing publications to citations.
The h index of Nature Reviews Drug Discovery Journal is 348, which means among all the published articles in this journal, 348 of these publications have received at least 348 citations each.
Journal Metrics
Nature Reviews Drug Discovery CiteScore
CiteScore (CS) of an academic journal is a measure reflecting the yearly average number of citations to recent articles published in that journal.
| Cites / Doc. (3 years) | 2018 | 9.913 |
| Cites / Doc. (3 years) | 2019 | 9.201 |
| Cites / Doc. (3 years) | 2020 | 12.384 |
| Cites / Doc. (3 years) | 2021 | 16.649 |
| Cites / Doc. (2 years) | 2018 | 9.057 |
| Cites / Doc. (2 years) | 2019 | 9.390 |
| Cites / Doc. (2 years) | 2020 | 12.062 |
| Cites / Doc. (2 years) | 2021 | 16.622 |
Nature Reviews Drug Discovery SCImago Rank
The SCImago Journal Rank (SJR) indicator is a measure of the scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where the citations come from.
| Year | SCImago Journal Rank (SJR) |
|---|---|
| 2018 | 9.483 |
| 2019 | 7.018 |
| 2020 | 9.921 |
| 2021 | 11.296 |
Nature Reviews Drug Discovery Editors
- Editor in Chief: Peter Kirkpatrick
- Senior Editor: Sarah Crunkhorn
- Senior Editor: M. Teresa Villanueva
- Senior Editor: Alex Eccleston
Nature Reviews Drug Discovery Publication Fee
Articles published in Nature Reviews can only be published using the subscription publication route. The journal does not offer an immediate gold open access (OA) publication option.
In the subscription publication route, no fee has to be paid by the author. The public or subscribers pays to access these journals. The visibility of such paper would be low compared to OA journals.
Nature Reviews Drug Discovery Review Time
Nature Reviews Drug Discovery prioritizes rapid publication and because its an open access journal, the papers are immediately available upon publication to the research community and beyond.
| Submission to First Decision | NA |
| Submission to first post-review decision | NA |
| Submission to accept | NA |
Nature Reviews Drug Discovery Reference Style
Nature Reviews Drug Discovery uses the standard Nature referencing style.
Printed journals
Schott, D. H., Collins, R. N. & Bretscher, A. Secretory vesicle transport velocity in living cells depends on the myosin V lever arm length. J. Cell Biol. 156, 35-39 (2002).
Online only
Bellin, D. L. et al. Electrochemical camera chip for simultaneous imaging of multiple metabolites in biofilms. Nat. Commun. 7, 10535; 10.1038/ncomms10535 (2016).
For papers with more than five authors include only the first author’s name followed by ‘et al.’.
Books:
Smith, J. Syntax of referencing in How to reference books (ed. Smith, S.) 180-181 (Macmillan, 2013).
Online material:
Babichev, S. A., Ries, J. & Lvovsky, A. I. Quantum scissors: teleportation of single-mode optical states by means of a nonlocal single photon. Preprint at https://arxiv.org/abs/quant-ph/0208066 (2002).
Manaster, J. Sloth squeak. Scientific American Blog Network http://blogs.scientificamerican.com/psi-vid/2014/04/09/sloth-squeak (2014).
Hao, Z., AghaKouchak, A., Nakhjiri, N. & Farahmand, A. Global integrated drought monitoring and prediction system (GIDMaPS) data sets. figshare https://doi.org/10.6084/m9.figshare.853801 (2014).
Nature Reviews Drug Discovery Endnote Style
You can download the Nature Reviews Drug Discovery Endnote Style and Nature Reviews Drug Discovery Zotero Style
Nature Reviews Drug Discovery Abbreviation
The ISO 4 standard abbreviation for abstracting, indexing, and referencing purposes of Nature Reviews Drug Discovery is “Nat. Rev. Drug Discov.“
Nature Reviews Drug Discovery Acceptance Rate
The acceptance rate of a journal is the ratio of the number of articles submitted to the number of articles published.
The average acceptance rate of Nature Reviews Drug Discovery journal is not known
Nature Reviews Drug Discovery Indexed in
Science is indexed in Scopus, SCImago, Web of Science, and UGC journal ranking
Read More
